Krystal Biotech (KRYS)
(Delayed Data from NSDQ)
$181.47 USD
-0.56 (-0.31%)
Updated Oct 1, 2024 04:00 PM ET
After-Market: $181.25 -0.22 (-0.12%) 7:58 PM ET
1-Strong Buy of 5 1
F Value C Growth D Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/4/24 |
---|---|
Current Quarter | 0.85 |
EPS Last Quarter | 0.86 |
Last EPS Surprise | 72.00% |
ABR | 1.18 |
Earnings ESP
|
0.00% |
---|---|
Current Year | 2.38 |
Next Year | 7.31 |
EPS (TTM) | 0.52 |
P/E (F1) | 76.54 |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 83.48M | 102.26M | 292.87M | 509.07M |
# of Estimates | 3 | 3 | 4 | 4 |
High Estimate | 85.40M | 114.07M | 315.00M | 587.90M |
Low Estimate | 81.64M | 93.91M | 267.70M | 464.20M |
Year ago Sales | 8.56M | 42.14M | 50.70M | 292.87M |
Year over Year Growth Est. | 875.23% | 142.67% | 477.66% | 73.82% |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 0.85 | 1.26 | 2.38 | 7.31 |
# of Estimates | 3 | 3 | 6 | 6 |
Most Recent Consensus | 0.89 | 0.97 | 2.42 | 5.91 |
High Estimate | 1.02 | 2.06 | 3.68 | 13.13 |
Low Estimate | 0.63 | 0.76 | 1.89 | 4.08 |
Year ago EPS | -0.67 | 0.30 | -2.76 | 2.38 |
Year over Year Growth Est. | 226.87% | 320.00% | 186.23% | 207.14% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 3 | 3 | 4 | 5 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 2 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | 0.85 | 1.26 | 2.38 | 7.31 |
7 Days Ago | 0.85 | 1.26 | 2.38 | 7.31 |
30 Days Ago | 0.85 | 1.26 | 2.38 | 7.31 |
60 Days Ago | 0.52 | 0.55 | 1.91 | 4.33 |
90 Days Ago | 0.52 | 0.55 | 1.98 | 4.33 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | 0.85 | 1.26 | 2.38 | 7.31 |
Zacks Consensus Estimate | 0.85 | 1.26 | 2.38 | 7.31 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | 0.86 | 0.03 | 0.30 | -0.67 | NA |
Estimate | 0.50 | 0.20 | -0.52 | -1.10 | NA |
Difference | 0.36 | -0.17 | 0.82 | 0.43 | 0.36 |
Surprise | 72.00% | -85.00% | 157.69% | 39.09% | 45.95% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more